Back to Search Start Over

Researchers Submit Patent Application, "Sodium Thiosulfate-Containing Pharmaceutical Compositions", for Approval (USPTO 20230183067).

Source :
Pharma Business Week; 7/3/2023, p10596-10596, 1p
Publication Year :
2023

Abstract

Consequently, there is a clear and unmet need for purified sodium thiosulfate pentahydrate raw material that is manufactured in accordance with "pharmaceutical grade" Good Manufacturing Practices and that meets the new set of quality specifications in order to translate recent sodium thiosulfate pentahydrate-related research discoveries into FDA-approved clinical therapies. Because of the relatively small quantity of sodium thiosulfate pentahydrate that is currently used to formulate pharmaceutical products, no raw material supplier presently manufactures sodium thiosulfate pentahydrate in accordance with "pharmaceutical grade" Good Manufacturing Practices. "Another hurdle in developing pharmaceutical grade sodium thiosulfate pentahydrate is the lack of an effective analytical method to determine total non-purgeable organic carbon in a sodium thiosulfate pentahydrate-containing sample, which is one of the new FDA-imposed quality standards. Currently available sodium thiosulfate pentahydrate injection that is labeled solely for use as a treatment of cyanide poisoning and sodium thiosulfate pentahydrate-containing lotion that is labeled solely for use as a treatment of tinea versicolor are "grandfathered medications". [Extracted from the article]

Details

Language :
English
ISSN :
15436675
Database :
Complementary Index
Journal :
Pharma Business Week
Publication Type :
Periodical
Accession number :
164631580